MDMA Toxicity Questions & Answers

1. Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021 Jun. 27 (6):1025-1033. [QxMD MEDLINE Link]. [Full Text].

2. Amoroso T. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder. J Psychoactive Drugs. 2015 Nov-Dec. 47 (5):337-44. [QxMD MEDLINE Link].

3. Inouye A, Wolfgang A. 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review. Cureus. 2022 Jun. 14 (6):e26402. [QxMD MEDLINE Link]. [Full Text].

4. US could soon approve MDMA therapy — opening an era of psychedelic medicine. Nature. Available at https://www.nature.com/articles/d41586-023-01296-3. April 19, 2023; Accessed: August 21, 2023.

5. MDMA. Multidisciplinary Association for Psychedelic Studies. Available at https://maps.org/mdma/. Accessed: August 21, 2023.

6. Armenian P, Mamantov TM, Tsutaoka BT, Gerona RR, Silman EF, Wu AH, et al. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. J Intensive Care Med. 2013 Jul-Aug. 28 (4):252-8. [QxMD MEDLINE Link].

7. McCann UD, Eligulashvili V, Ricaurte GA. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology. 2000. 42(1):11-6. [QxMD MEDLINE Link].

8. Ricaurte GA, Martello AL, Katz JL, Martello MB. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther. 1992 May. 261(2):616-22. [QxMD MEDLINE Link].

9. Steele TD, McCann UD, Ricaurte GA. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction. 1994 May. 89(5):539-51. [QxMD MEDLINE Link].

10. Schwartz RH, Miller NS. MDMA (ecstasy) and the rave: a review. Pediatrics. 1997 Oct. 100(4):705-8. [QxMD MEDLINE Link].

11. Boels D, Grall-Bronnec M, Guerlais M, Le Roux G, Spiers A, Gerardin M, et al. Parachuting: a dangerous trend in recreational psychoactive substance delivery. Expert Opin Drug Deliv. 2017 Apr. 14 (4):491-498. [QxMD MEDLINE Link].

12. Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. J Psychopharmacol. 2012 Mar. 26(3):408-18. [QxMD MEDLINE Link].

13. Nadkarni GN, Hoskote SS, Piotrkowski J, Annapureddy N. Serotonin Syndrome, Disseminated Intravascular Coagulation, and Hepatitis After a Single Ingestion of MDMA in an Asian Woman. Am J Ther. 2012 Jun 16. [QxMD MEDLINE Link].

14. Cunningham M. Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure. Intensive Crit Care Nurs. 1997 Aug. 13(4):216-23. [QxMD MEDLINE Link].

15. Fahal IH, Sallomi DF, Yaqoob M, Bell GM. Acute renal failure after ecstasy. BMJ. 1992 Jul 4. 305(6844):29. [QxMD MEDLINE Link].

16. Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M. Low-dose MDMA ("ecstasy") induces vasopressin secretion. Lancet. 1998 Jun 13. 351(9118):1784. [QxMD MEDLINE Link].

17. Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA). Lancet. 1996 Apr 13. 347(9007):1052. [QxMD MEDLINE Link].

18. Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F. Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol. 2010 Aug. 11(5):476-95. [QxMD MEDLINE Link].

19. Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology (Berl). 2000 Feb. 148(3):322-4. [QxMD MEDLINE Link].

20. National Institute on Drug Abuse. National Survey of Drug Use and Health: 2021 NSDUH Detailed Tables. Samhsa.gov. Available at https://www.drugabuse.gov/national-survey-drug-use-health. January 4, 2023; Accessed: January 21, 2023.

21. Palamar JJ, Keyes K, Cleland CM. Underreporting of ecstasy use among high school seniors in the US. Drug Alcohol Depend. 2016 Jun 6. [QxMD MEDLINE Link].

22. Wish ED, Fitzelle DB, O'Grady KE, Hsu MH, Arria AM. Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health. 2006 Sep-Oct. 55(2):99-104. [QxMD MEDLINE Link]. [Full Text].

23. Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, et al. 2021 Annual Report of the National Poison Data System(©) (NPDS) from America's Poison Centers: 39th Annual Report. Clin Toxicol (Phila). 2022 Dec. 60 (12):1381-1643. [QxMD MEDLINE Link]. [Full Text].

24. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2022: Trends and Developments,. Luxembourg: Publications Office of the European Union; 2021. [Full Text].

25. United Nations Office on Drugs and Crime (UNODC). Drug Market Trends: Cocaine Amphetamine-type Stimulants and New Psychoactive Substances. World Drug Report 2022: Booklet 4. United Nations publication, Sales No. 22.XI.8; June 2022. [Full Text].

26. Monitoring the Future Study: Trends in Prevalence of Various Drugs. National Institute on Drug Abuse. Available at https://www.drugabuse.gov/trends-statistics/monitoring-future/monitoring-future-study-trends-in-prevalence-various-drugs. December 15, 2022; Accessed: January 21, 2023.

27. O'Shea E, Escobedo I, Orio L, et al. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology. 2005 Jul. 30(7):1312-23. [QxMD MEDLINE Link].

28. Lai TI, Hwang JJ, Fang CC, Chen WJ. Methylene 3, 4 dioxymethamphetamine-induced acute myocardial infarction. Ann Emerg Med. 2003 Dec. 42(6):759-62. [QxMD MEDLINE Link].

29. Papaseit E, Pérez-Mañá C, Mateus JA, Pujadas M, Fonseca F, Torrens M, et al. Human Pharmacology of Mephedrone in Comparison to MDMA. Neuropsychopharmacology. 2016 May 20. [QxMD MEDLINE Link].

30. Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. CJEM. 2010 Sep. 12(5):435-42. [QxMD MEDLINE Link].

31. Kiyatkin EA, Ren S, Wakabayashi KT, Baumann MH, Shaham Y. Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction. Neuropsychopharmacology. 2016 Jan. 41 (2):549-59. [QxMD MEDLINE Link].

In-Hei Hahn, MD, FACEP, FACMT Attending Physician, Department of Emergency Medicine, NYU Langone-Cobble Hill

In-Hei Hahn, MD, FACEP, FACMT is a member of the following medical societies: American College of Emergency Physicians, American College of Medical Toxicology, Wilderness Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

John G Benitez, MD, MPH Associate Professor, Department of Medicine, Medical Toxicology, Vanderbilt University Medical Center; Managing Director, Tennessee Poison Center

John G Benitez, MD, MPH is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American College of Medical Toxicology, American College of Preventive Medicine, Undersea and Hyperbaric Medical Society, Wilderness Medical Society, American College of Occupational and Environmental Medicine

Disclosure: Nothing to disclose.

Jeter (Jay) Pritchard Taylor, III, MD Assistant Professor, Department of Surgery, University of South Carolina School of Medicine; Attending Physician / Clinical Instructor, Compliance Officer, Department of Emergency Medicine, Prisma Health Richland Hospital

Jeter (Jay) Pritchard Taylor, III, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Columbia Medical Society, Society for Academic Emergency Medicine, South Carolina College of Emergency Physicians, South Carolina Medical Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Employed contractor - Chief Editor for Medscape.

Peter MC DeBlieux, MD Professor of Clinical Medicine and Pediatrics, Section of Pulmonary and Critical Care Medicine, Program Director, Department of Emergency Medicine, Louisiana State University School of Medicine in New Orleans

Peter MC DeBlieux, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Radiological Society of North America, Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Asim Tarabar, MD Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article